MedDataX Logo

Fluid Balance During Surgery for Ovarian Cancer

NCT ID: NCT03006939

Last Updated: 2016-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-12-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Extensive tumour debulking challenges both surgeon and anaesthesiologist but promotes survival in late-stage ovarian cancer patients. Little is known about the intraoperative fluid balance and its impact on morbidity and mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Neoplasm Fluid Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cytoreductive surgery

Cytoreductive surgery in terms of tumor debulking is performed in order to promote survival

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients scheduled for cytoreductive surgery in ovarian cancer

Exclusion Criteria

* Age \< 18 years
* unability to give consent
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bonn

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Martin Soehle

Vice head of the department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martin Soehle, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Clinic Bonn

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept. of Anaesthesiology and Intensive Care Medicine, University of Bonn

Bonn, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Martin Soehle, MD, PhD

Role: CONTACT

Phone: 0049-228-287-

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Martin Soehle, MD, PhD

Role: primary

Claudia Neumann, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FBO

Identifier Type: -

Identifier Source: org_study_id